Is Bristol-Myers Squibb Making Money?

Interestingly, the Bristol-Myers Squibb Co. (NYSE: BMY) is generating more cash. For instance, Bristol-Myers reported a quarterly operating cash flow of $1.39 billion in March 2019 that grew to $3.894 billion in March 2020.

Read more

Why is NVIDIA (NVDA) Surging?

Moreover, NVIDIA manufactures the building blocks for the “brains” of autonomous vehicles and robots. To explain, NVIDIA builds both the hardware (GPUs) and software (the NVIDIA Drive Scalable AI Platform for Autonomous Driving) self-driving vehicles need to operate.

Read more

Can Gilead Sciences (NASDAQ: GILD) make money from Coronavirus?

Gilead offers many antivirals, including 12 treatments for HIV/AIDS. In addition, Gilead offers treatments for liver disease, inflammation and respiratory disease, the flu, and more. Popular Gilead products include Tamiflu, Sovaldi, Viread, and Descovy.

Read more

Are the Monster Banks making Money at Wells Fargo & Bank of America?

Hence, the two monster banks’ revenue growth rates were shrinking before coronavirus. Now that revenue growth is collapsing rather than shrinking.

Read more

Is Buffett Right about Teva?

One of Warren Buffett’s oddest stock holdings is the Israeli/American drug maker Teva Pharmaceutical Industries Ltd (NYSE: TEVA). Teva is cheap;

Read more

Is Ecolab Making Money?

Consequently, Ecolab’s business could explode because of the latest disease hysteria. However, Ecolab’s business could shrink if events show Coronavirus is not a threat.

Read more

Target and the Art of Retail Survival

Significantly, Target is generating less cash. In particular, Target’s free cash flow fell from $1.755 billion on 3 August 2019 to $357 million on 2 November 2019. However, Target’s free cash flow rose from -$327 million on 4 May 2019.

Read more